aTyr Pharma Inc (NASDAQ:LIFE)

1.14
Delayed Data
As of 3:13pm ET
 -0.0308 / -2.63%
Today’s Change
0.80
Today|||52-Week Range
6.50
-67.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line-12.1M-11.2M-11.5M-10.7M
 
 
 
 
 
Depreciation174.0K152.0K161.0K184.0K
 
 
 
 
 
Total Other Cash Flow1.3M1.2M3.1M945.0K
 
 
 
 
 
Funds From Operations-10.7M-9.8M-8.2M-9.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.4M-898.0K2.1M1.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-9.3M-8.9M-10.3M-10.6M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-53.8M-12.4M-8.0M
 
 
 
 
Decrease In Investments11.7M14.5M9.0M19.9M
 
 
 
 
 
Capital Expenditures-449.0K-441.0K-160.0K-498.0K
 
 
 
 
 
Net Cash Flow Investing11.3M-39.8M-3.5M11.4M
 
 
 
 
 
 
FinancingShort Term Borrowings------0.00--
Long Term Borrowings4.9M0.004.9M--
 
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale86.0K42.5M226.0K8.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing5.0M42.5M5.2M8.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash7.0M-6.2M-8.7M845.0K